Design (Testphase)
Breakout & Setup
Oops Reversal
122
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Oops Reversal (Larry Williams bottom reversal): the stock gaps down below the prior day's low at the open — typical after bad news or panic — but then buyers step in and push the price back above the prior day's close. This reversal itself is the buy signal. It often marks a local low with clearly defined risk (stop below the day's low). Calculated from daily prices.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Gap
- The stock opens well above or below the prior close - a gap appears on the chart. Gaps are caused by overnight news (earnings, contracts, studies) and show that the valuation has shifted abruptly.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience, Inc. | 08/12 | — | 89 8/22 | Stage 2 | D -49 | 2 of 9 | 0.9 | Biotechnology | – | — | — | Healthcare | 25.90 $ | +37.3 % | +41.2 % | +942.3 % | −11.0 % | +38.9 % | 99 | 42 | 8.0 % | 7.7 % | 1.07 | — | 0.0 | — | 3.7 | — | — | 0.0 | — | — | 0.0 % | -38.9 % | -21.7 % | 0.02 | — | -100.0 % | 0.0 % | 0.0 % | 12.7 | 82.1 % | 5.5 % | — |
| WULF Terawulf Inc | 08/14 | +500 % | 53 5/22 | Stage 2 | D -24 | 2 of 9 | 13.1 | Capital Markets | – | — | — | Financial Services | 18.90 $ | +150.5 % | +107.8 % | +655.5 % | −12.7 % | +39.4 % | 98 | 42 | 8.4 % | 8.3 % | 4.26 | — | 89.3 | 77.8 | 84.3 | — | — | 109.7 | -366.2 % | 64.0 % | 0.0 % | -2,216.0 % | -3.4 % | -67.46 | -1.1 % | +20.3 % | 0.0 % | 0.0 % | 2.8 | 82.5 % | 25.8 % | 1.1 (11) |
| KOD Kodiak Sciences Inc | 08/12 | +137 % | 40 4/22 | Stage 2 | E -55 | 2 of 9 | 2.1 | Biotechnology | – | — | — | Healthcare | 40.90 $ | +32.5 % | +21.4 % | +891.7 % | −28.7 % | +83.8 % | 98 | 42 | 8.0 % | 7.7 % | 2.20 | — | 0.0 | — | — | — | — | -0.1 | 0.0 % | — | 0.0 % | -208.8 % | -49.1 % | — | 36.6 % | — | 0.0 % | 0.0 % | -15.7 | 99.6 % | 26.6 % | 2.3 (6) |
| ARTV Artiva Biotherapeutics, Inc. Common Stock | 08/05 | — | 70 6/22 | Stage 2 | E -62 | 2 of 9 | 0.4 | Biotechnology | – | — | — | Healthcare | 9.20 $ | +128.4 % | +122.8 % | +475.3 % | −39.2 % | +305.4 % | 98 | 42 | 10.4 % | 10.4 % | — | — | 0.0 | — | 5.3 | — | — | 0.0 | — | — | 0.0 % | -67.9 % | -38.7 % | 0.12 | — | -100.0 % | 0.0 % | 0.0 % | -3.3 | 51.3 % | 3.2 % | — |
| KLIC Kulicke and Soffa Industries Inc | 08/05 | +47 % | 60 6/25 | Stage 2 | B +28 | 6 of 9 | 6.9 | Semiconductor Equipment & Ma | Neutral | — | Technology | 100.10 $ | +180.3 % | +179.3 % | +270.3 % | −1.4 % | -23.9 % | 97 | 6 | 7.6 % | 6.8 % | 1.63 | 120.4 | 28.4 | 9.0 | 8.0 | 1,600.0 | 2.38 | 67.5 | 15.9 % | 49.8 % | 7.2 % | 6.4 % | 3.9 % | 0.05 | 72.3 % | -7.4 % | 0.7 % | 51.9 % | 13.9 | 93.1 % | 4.2 % | 1.4 (5) | |
| MBX MBX Biosciences, Inc. Common Stock | 08/06 | — | 69 6/22 | Stage 2 | D -33 | 3 of 9 | 2.3 | Biotechnology | – | — | — | Healthcare | 60.10 $ | +47.1 % | +67.7 % | +397.4 % | −4.1 % | +37.2 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 5.5 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 16.8 % | 1.0 (5) |
| APLD Applied Digital Corporation | 07/29 | +153 % | 60 6/25 | Stage 2 | B +24 | 5 of 9 | 12.0 | Information Technology Servi | Sells AI | — | Technology | 27.90 $ | +84.6 % | +46.9 % | +325.3 % | −19.3 % | +79.2 % | 96 | 42 | 8.8 % | 9.9 % | 5.68 | — | 526.3 | 33.9 | 7.4 | — | 1.83 | -7.4 | -20.5 % | 45.4 % | -59.5 % | -5.6 % | -0.6 % | 1.79 | 25.3 % | +57.7 % | 0.0 % | 0.0 % | 4.7 | 71.9 % | 28.3 % | 1.1 (9) | |
| TVTX Travere Therapeutics Inc | 08/05 | +82 % | 68 6/22 | Stage 2 | B +27 | 5 of 9 | 5.4 | Biotechnology | Uses AI | — | — | Healthcare | 55.50 $ | +46.4 % | +44.7 % | +298.1 % | −1.8 % | -1.1 % | 96 | 42 | 3.6 % | 4.6 % | 1.11 | — | 78.1 | 10.1 | 54.3 | 308.7 | — | 139.0 | -29.0 % | 56.0 % | -4.0 % | -69.4 % | -6.5 % | 3.35 | 17.8 % | +110.5 % | 0.0 % | 0.0 % | -2.7 | 113.4 % | 18.9 % | 1.1 (15) |
| RIOT Riot Platforms, Inc. | 07/30 | +49 % | 78 7/22 | Stage 2 | D -38 | 2 of 9 | 10.6 | Capital Markets | Sells AI | — | Financial Services | 19.90 $ | +126.4 % | +99.4 % | +195.8 % | −8.4 % | +5.0 % | 95 | 74 | 7.9 % | 7.5 % | 3.81 | — | 37.6 | 16.2 | 4.4 | — | — | 11.4 | -280.5 % | 32.4 % | -132.8 % | -32.5 % | -12.1 % | 0.39 | 69.7 % | +71.9 % | 0.0 % | 0.0 % | 3.1 | 81.6 % | 15.9 % | 1.1 (16) | |
| ATRO Astronics Corporation | 08/05 | +154 % | 76 9/29 | Stage 2 | B +13 | 6 of 9 | 4.3 | Aerospace & Defense | Neutral | — | Industrials | 67.30 $ | +91.0 % | +94.2 % | +217.7 % | −12.8 % | -12.6 % | 95 | 89 | 6.0 % | 5.8 % | 1.13 | — | 27.2 | 4.8 | — | 171.7 | 1.45 | 34.3 | 11.8 % | 31.4 % | 5.1 % | 21.2 % | 9.0 % | — | 21.6 % | +8.4 % | 0.0 % | 0.0 % | 7.9 | 101.1 % | 6.7 % | 1.7 (3) | |
| ELVN Enliven Therapeutics Inc. | 08/12 | +44 % | 69 6/22 | Stage 2 | D -44 | 4 of 9 | 3.3 | Biotechnology | – | — | — | Healthcare | 51.70 $ | +215.6 % | +203.9 % | +135.4 % | −2.8 % | +32.6 % | 95 | 42 | 6.6 % | 6.9 % | 0.26 | — | 0.0 | — | 7.9 | — | — | -6.3 | 0.0 % | — | 0.0 % | -26.6 % | -18.9 % | 0.00 | 97.5 % | — | 0.0 % | 0.0 % | 47.0 | 89.7 % | 11.1 % | 1.0 (8) |
| CAPR Capricor Therapeutics Inc | 08/10 | +8 % | 69 6/22 | Stage 2 | E -53 | 3 of 9 | 1.7 | Biotechnology | – | — | — | Healthcare | 19.50 $ | +2.6 % | -19.8 % | +284.2 % | −24.7 % | +76.3 % | 95 | 42 | 7.5 % | 5.7 % | 0.42 | — | 78.7 | — | — | — | 0.38 | -2.7 | 0.0 % | -834.8 % | 0.0 % | -56.4 % | -31.2 % | — | 85.4 % | -100.0 % | 0.0 % | 0.0 % | 8.7 | 59.7 % | 22.3 % | 1.0 (8) |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B +28 | 7 of 9 | 8.2 | Healthcare Plans | Uses AI | — | — | Healthcare | 29.60 $ | +108.3 % | +97.3 % | +42.8 % | −5.6 % | -21.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.6 | 5.3 | 2.9 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | 0.0 % | 0.0 % | 3.0 | 67.6 % | 7.1 % | 1.9 (7) |
| XMTR Xometry Inc | 08/04 | +114 % | 66 8/29 | Stage 2 | B +30 | 5 of 9 | 5.1 | Industrial Distribution | – | — | — | Industrials | 100.10 $ | +54.3 % | +48.6 % | +183.3 % | −7.3 % | -3.7 % | 94 | 42 | 4.8 % | 5.7 % | 1.27 | — | 119.0 | 6.9 | 18.0 | — | — | -13.1 | -2.5 % | 39.3 % | -7.0 % | -17.5 % | -3.1 % | 1.21 | 38.1 % | +25.9 % | 0.0 % | 0.0 % | 3.0 | 96.4 % | 7.5 % | 1.4 (10) |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C +1 | 3 of 9 | 8.0 | Biotechnology | Uses AI | — | — | Healthcare | 7.50 $ | +269.7 % | +309.8 % | +182.6 % | −37.3 % | +66.9 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 57.1 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.8 % | 1.0 (5) |
| SEPN Septerna, Inc. Common Stock | 08/10 | — | — | Stage 2 | C -4 | 4 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 32.20 $ | +31.2 % | +17.9 % | +242.4 % | −9.1 % | +30.3 % | 94 | 50 | 7.5 % | 6.9 % | — | — | 107.5 | — | — | — | — | 0.0 | — | 100.0 % | -49.9 % | -9.3 % | -8.5 % | — | — | +4,174.5 % | 0.0 % | 0.0 % | 7.0 | 102.7 % | 11.7 % | — |
| STRZ Starz Entertainment LLC | — | — | — | Stage 2 | E -64 | 4 of 9 | 0.0 | Entertainment | – | — | — | Communication Services | 27.30 $ | +143.2 % | +152.5 % | +56.3 % | −9.7 % | +15.0 % | 94 | 50 | 6.8 % | 7.1 % | — | — | 3.6 | — | — | — | — | 1.7 | — | 50.7 % | -13.2 % | -34.7 % | -0.8 % | — | — | -8.2 % | 0.0 % | 0.0 % | 1.3 | 92.3 % | 3.7 % | — |
| CORZ Core Scientific, Inc. Common Stock | 08/14 | — | 46 5/25 | Stage 2 | C -9 | 4 of 9 | 8.6 | Software - Infrastructure | – | — | — | Technology | 22.40 $ | +100.3 % | +66.6 % | +144.9 % | −10.5 % | +20.5 % | 93 | 80 | 6.3 % | 6.5 % | 5.50 | — | 166.7 | 24.4 | 0.0 | — | — | 454.9 | -18.8 % | 21.6 % | 0.0 % | 0.0 % | -4.3 % | -1.57 | -42.5 % | -37.5 % | 0.0 % | 0.0 % | -5.1 | 124.5 % | 26.6 % | 1.1 (16) |
| GSAT Globalstar, Inc. Common Stock | 08/06 | +150 % | 89 9/24 | Stage 2 | D -23 | 5 of 9 | 10.3 | Telecom Services | – | — | — | Communication Services | 79.30 $ | +30.9 % | +28.3 % | +236.9 % | −5.6 % | +12.6 % | 93 | 42 | 1.5 % | 1.5 % | 1.54 | — | 9.2 | 36.4 | 30.0 | 533.4 | 0.50 | 97.6 | 16.3 % | 63.7 % | -3.1 % | -2.5 % | 0.8 % | 1.54 | 14.4 % | +9.0 % | 0.0 % | 0.0 % | 1.0 | 26.3 % | 7.3 % | 1.3 (3) |
| LASR nLIGHT Inc | 08/06 | +113 % | 73 7/25 | Stage 2 | B +43 | 7 of 9 | 3.5 | Semiconductors | – | — | — | Technology | 68.30 $ | +77.1 % | +65.4 % | +262.6 % | −28.2 % | +38.4 % | 93 | 42 | 7.4 % | 8.0 % | 2.30 | — | 123.5 | 12.2 | 8.0 | 159.5 | 1.78 | 2,776.6 | -0.5 % | 31.3 % | -5.1 % | -4.6 % | -2.3 % | 0.08 | 83.2 % | +31.6 % | 0.0 % | 0.0 % | 11.0 | 92.1 % | 4.5 % | 1.1 (7) |
| CCCC C4 Therapeutics Inc | 08/06 | -23 % | 57 5/22 | Stage 2 | D -27 | 4 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 3.60 $ | +120.9 % | +109.1 % | +189.1 % | −4.3 % | +203.0 % | 93 | 42 | 7.7 % | 9.3 % | 2.91 | — | 0.0 | 14.4 | 2.1 | — | — | -0.4 | — | 78.3 % | -297.8 % | -48.4 % | -19.9 % | 0.25 | — | +1.0 % | 0.0 % | 0.0 % | 0.5 | 85.1 % | 20.3 % | — |
| ULCC Frontier Group Holdings Inc | 08/04 | -7 % | 49 6/29 | Stage 2 | D -18 | 3 of 9 | 1.8 | Airlines | – | — | — | Industrials | 6.20 $ | +53.9 % | +55.0 % | +112.0 % | −4.1 % | -23.5 % | 92 | 52 | 7.3 % | 7.6 % | 2.57 | — | 13.9 | 0.5 | 7.7 | — | — | 100.0 | — | -2.0 % | -9.6 % | -92.4 % | -6.3 % | 23.64 | — | -1.4 % | 0.0 % | 0.0 % | 1.7 | 55.2 % | 41.0 % | — |
| ROIV Roivant Sciences Ltd | 08/10 | +76 % | 38 4/22 | Stage 2 | D -13 | 3 of 9 | 23.8 | Biotechnology | Uses AI | — | — | Healthcare | 34.10 $ | +48.4 % | +54.4 % | +195.7 % | −1.9 % | +14.8 % | 91 | 2 | 3.9 % | 4.0 % | 1.11 | — | 0.0 | 2,867.0 | 5.4 | — | — | 0.7 | -14,675.1 % | -8,159.0 % | 0.0 % | -7.6 % | -14.4 % | 0.02 | 79.0 % | -71.6 % | 0.0 % | 0.0 % | 19.2 | 75.9 % | 6.1 % | 1.1 (10) |
| KGS Kodiak Gas Services, Inc. | 08/05 | — | 98 5/10 | Stage 2 | B +11 | 7 of 9 | 7.4 | Oil & Gas Equipment & Servic | – | — | — | Energy | 64.50 $ | +94.9 % | +106.1 % | +116.8 % | −4.8 % | +13.7 % | 91 | 17 | 4.1 % | 3.8 % | 0.82 | 93.0 | 32.1 | 5.6 | 6.4 | 36.8 | — | 17.7 | 33.7 % | 64.2 % | 5.1 % | 5.4 % | 6.0 % | 0.06 | 26.1 % | +12.8 % | 2.8 % | 120.8 % | 4.2 | 91.3 % | 8.5 % | 1.2 (11) |
| LIND Lindblad Expeditions Holdings Inc | 08/03 | +50 % | 43 6/31 | Stage 2 | B +32 | 8 of 9 | 1.9 | Travel Services | – | — | — | Consumer Cyclical | 27.60 $ | +78.7 % | +94.4 % | +143.1 % | −1.1 % | -9.8 % | 91 | 94 | 5.8 % | 5.4 % | 2.23 | — | 217.4 | 2.4 | 159.8 | 22.7 | — | 22.2 | 7.5 % | 46.0 % | -3.1 % | -1,946.9 % | 3.8 % | -3.50 | -19.3 % | +19.6 % | 0.0 % | 0.0 % | 1.3 | 75.0 % | 10.9 % | 1.3 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Oops Reversal (Larry Williams bottom reversal): the stock gaps down below the prior day's low at the open — typical after bad news or panic — but then buyers step in and push the price back above the prior day's close. This reversal itself is the buy signal. It often marks a local low with clearly defined risk (stop below the day's low). Calculated from daily prices.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 122 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- ATH
- Ants
- Ben Bennett: Power of Four
- Bullish Reversal Bar
- Gap-Up (≥3%)
- Green Line Breakout
- High ADR — Hot Theme
- Inside Day
- Inside Day at Highs
- Mark Minervini: Power Play
- Oliver Kell: Bull Snorts
- Oliver Kell: Gappers
- Pocket Pivot
- Pradeep Bonde: $ Breakout Bullish
- Pradeep Bonde: 4% Breakout Bullish
- Qullamaggie: Continuation Base
- Qullamaggie: Episodic Pivot
- Qullamaggie: High Tight Flag
- Strong DCR (≥80)
- Tight & Near High
- Tight Weekly Closes
- Tight Weekly Range (WCR≥90)
- Volume Surge
- Volume Surge
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.